Companies › LPCN

LIPOCINE INC NEW (LPCN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001535955 · EDGAR filings · Updated 2026-06-30

LIPOCINE INC NEW (LPCN) has reported institutional ownership of 42.7%, with 47 institutional managers holding positions valued at $24.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Latest updates

• 2026-06-30 — Insider transaction reported (Form 4)
• 2026-06-12 — Current report (8-K) filed
• 2026-06-09 — Employee-plan registration (S-8) filed
• 2026-06-04 — Current report (8-K) filed
• 2026-06-04 — Insider transaction reported (Form 4)
• 2026-06-04 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LIPOCINE INC NEW has 47 institutional holders and institutional ownership of 42.7%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

SANGAMO THERAPEUTICS INC (SGMOQ) · SANARA MEDTECH INC (SMTI) · VERRICA PHARMACEUTICALS INC (VRCA) · TELIX PHARMACEUTICAL LTD (TLX) · GYRE THERAPEUTICS INC (GYRE) · GENELUX CORPORATION (GNLX)